The U.S. supplemental health market size accounted for USD 40.58 billion in 2025 and is forecasted to hit around USD 66.45 billion by 2034, representing a CAGR of 5.60% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Supplemental Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Supplemental Health Market, by Product
8.1.1 Critical Illness Insurance
8.1.1.1. Market Revenue and Forecast
8.1.2. Accident Insurance
8.1.2.1. Market Revenue and Forecast
8.1.3. Hospital Indemnity Insurance
8.1.3.1. Market Revenue and Forecast
8.1.4. Worksite Life
8.1.4.1. Market Revenue and Forecast
8.1.5. Dental
8.1.5.1. Market Revenue and Forecast
9.1. U.S. Supplemental Health Market, by Distribution Channel
9.1.1. Direct-to-Consumer (DTC)
9.1.1.1. Market Revenue and Forecast
9.1.2. Agents
9.1.2.1. Market Revenue and Forecast
9.1.3. Brokers
9.1.3.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. U.S. Supplemental Health Market, by Demography
10.1.1. Individuals Aged 65 and Above
10.1.1.1. Market Revenue and Forecast
10.1.2. Individuals Aged Below 65 with an Eligible Disability
10.1.2.1. Market Revenue and Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Distribution Channel
11.1.3. Market Revenue and Forecast, by Demography
12.1. Aetna Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Allianz S.E.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. American International Group, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Anthem, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Assurant, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AXA Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cigna Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Humana Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. MetLife, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Zurich Insurance Group AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client